Compare AAT & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AAT | RAPP |
|---|---|---|
| Founded | 1967 | 2022 |
| Country | United States | United States |
| Employees | 208 | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2010 | 2024 |
| Metric | AAT | RAPP |
|---|---|---|
| Price | $20.86 | $36.57 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $19.50 | ★ $48.50 |
| AVG Volume (30 Days) | 312.5K | ★ 329.4K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 6.57% | N/A |
| EPS Growth | N/A | ★ 24.34 |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $436,204,000.00 | N/A |
| Revenue This Year | $4.33 | N/A |
| Revenue Next Year | $0.22 | N/A |
| P/E Ratio | $22.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.72 | $7.73 |
| 52 Week High | $21.40 | $42.27 |
| Indicator | AAT | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 73.36 | 62.24 |
| Support Level | $18.44 | $25.48 |
| Resistance Level | $21.08 | $41.59 |
| Average True Range (ATR) | 0.32 | 1.91 |
| MACD | 0.14 | -0.01 |
| Stochastic Oscillator | 98.78 | 54.92 |
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.